AIM
CNCE

Acrospire Investment Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Acrospire Investment Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,812
Closed -$32K – 2219
2016
Q2 		$32K Sell
2,812
-4,300
-60% -$48.9K 0.02% 1355
2016
Q1 		$97K Buy
+7,112
New +$97K 0.07% 343